Medicine (Baltimore)
July 2025
The angiotensin-converting enzyme 2/angiotensin (1-7) [Ang (1-7)]/Mas axis is recognized for its beneficial impact on pancreatic β-cell function and survival. However, the precise mechanisms underlying these benefits remain incompletely elucidated. This study aimed to elucidate the role of Ang (1-7) in pancreatic β-cells and determine whether autophagy is a critical factor in this mechanism.
View Article and Find Full Text PDFObjectives: Our objective was to compare the clinical features of Metabolic dysfunction-associated steatotic liver disease (MASLD) /metabolic alcohol-related liver disease (MetALD)/metabolic associated fatty liver disease (MAFLD)/nonalcoholic fatty liver disease (NAFLD) and the relative risk analysis of metabolic disorders.
Methods: The National Health and Nutrition Examination Survey for the 2017-2018 cycle was used to screen the participants. Multivariate-adjusted logistic regression models were applied to explore the difference in relative risk analysis between NAFLD/MAFLD/MASLD/MetALD and metabolic disorders.
Shengmai San (SMS) is a traditional Chinese medicine formula used for supplementing and and can mitigate symptoms related to malignant arrhythmia and heart failure. This systematic review aimed at exploring the effectiveness and safety of SMS for viral myocarditis (VMC). Eight databases from their inception to June 2023 were searched to identified randomized controlled trials (RCTs) focusing on SMS for VMC.
View Article and Find Full Text PDFIntegr Med Res
June 2024
Aims: This study aimed to synthesize the evidence of the comparative effectiveness and safety of () preparations combined with renin-angiotensin system inhibitors (RASi) for diabetic kidney disease (DKD).
Methods: Eight databases were searched from their inception to May 2023. Systematic reviews (SRs) of preparations combined with RASi for DKD were identified.
BMC Complement Med Ther
November 2021
Integr Cancer Ther
October 2021
Background: Traditional Chinese medicine (TCM) is widely integrated into cancer care in China. An overview in 2011 identified 2384 randomized and non-randomized controlled trials (RCTs, non-RCTs) on TCM for cancer published in the Chinese literature. This article summarizes updated evidence of RCTs on TCM for cancer care.
View Article and Find Full Text PDFThe corona virus disease-2019 (COVID-19) pandemic spread globally, and we aimed to investigate the psychosocial impact on healthcare workers (HWs) in China during the pandemic. In this systematic review and meta-analysis, we searched seven electronic databases for cross-sectional studies on psychosocial impact on HWs in relation to COVID-19 from January 1, 2020 to October 7, 2020. We included primary studies involving Chinese HWs during the pandemic, and data were extracted from the published articles.
View Article and Find Full Text PDFComplement Ther Med
August 2020
Objectives: This systematic review assessed whether Tuina (therapeutic massage) is more effective and safer than no treatment or routine medical treatment for irritable bowel syndrome (IBS).
Methods: Eleven databases were searched for randomized controlled trials of IBS diagnosed based on Manning or Rome criteria. Tuina with or without routine treatments (RTs) was tested against RTs.
Integr Med Res
September 2020
Cochrane Database Syst Rev
June 2019
Objective: To assess the effects and associated risks of Chinese herbal medicine (CHM) for diabetic foot ulcer (DFU).
Methods: We systematically searched seven electronic databases for randomized controlled trials (RCTs) about Chinese herbal medicines for treating diabetic foot ulcers. The methodological quality of RCTs was assessed by the Cochrane risk of bias tool.
Cochrane Database Syst Rev
April 2019
J Altern Complement Med
September 2019